B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ALPHA-2C

MOLECULAR TARGET

Alpha-2C adrenergic receptor (human)

UniProt: P1882534 compounds

ALPHA-2C (Alpha-2C adrenergic receptor (human)) is targeted by 34 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ALPHA-2C

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Yohimbine2.208
2Guanfacine1.393
3Mianserin1.102
4Quetiapine Fumarate1.102
5Sertraline1.102
6Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent1.102
7Amoxapine1.102
8Astemizole Antihistamine drug now withdrawn from1.102
9Bromocriptine1.102
10Carvedilol1.102
11Cinnarizine1.102
12Cyproheptadine1.102
13Dexmedetomidine1.102
14Dihydroergotamine1.102
15Domperidone1.102
16Emetine1.102
17Epinephrine1.102
18Ergotamine1.102
19Flunarizine Flunarizine is1.102
20Guanabenz1.102
21Hexachlorophene1.102
22Irinotecan1.102
23Lisuride1.102
24Maprotiline1.102
25Metergoline1.102
26Nortriptyline1.102
27Oxymetazoline1.102
28Pergolide1.102
29Phentolamine1.102
30Promethazine1.102
31Trazodone1.102
32Clonidine0.691
33Danazol0.691
34Norepinephrine Precursor of epinephrine that is secreted by0.691

About ALPHA-2C as a Drug Target

ALPHA-2C (Alpha-2C adrenergic receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 34 compounds with documented ALPHA-2C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ALPHA-2C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.